A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting

Condition:   Vaginal AtrophyInterventions:   Drug: estriol;   Drug: PlaceboSponsors:   ITF Research Pharma, S.L.U.;   Spanish Breast Cancer Research GroupRecruiting - verified April 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials